<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02369419</url>
  </required_header>
  <id_info>
    <org_study_id>RNI2013-02-DR-KUBALA</org_study_id>
    <nct_id>NCT02369419</nct_id>
  </id_info>
  <brief_title>Frailty Score Assessment for Elderly Patients Undergoing Cardiac Resynchronization Therapy</brief_title>
  <acronym>FRAILTY</acronym>
  <official_title>Frailty Score Assessment for Elderly Patients Undergoing Cardiac Resynchronization Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: The cardiac resynchronization therapy (CRT) has been shown to improve symptoms
      and outcome of patients with congestive heart failure (HF), and depressed left ventricular
      ejection fraction (LVEF &lt; 35 %). The rate of non-responders to CRT is estimated at 30 %. Yet,
      the impact of frailty on the response to CRT has not been studied, until now.

      Purpose : To assess the impact of frailty in the elderly, on the response to CRT.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods : Frailty is evaluated before implant ,and defined as &lt;14/17 points using the
      ONCODAGE score, in 150 patients of &gt; 70 years age, selected for CRT according to the ESC 2013
      guidelines. The response to CRT, estimated at 9 months, is defined as an improvement of at
      least 5 % of the LVEF and the absence of HF hospitalization or cardiovascular death.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>non response on CRT</measure>
    <time_frame>9 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>seric albumin</measure>
    <time_frame>9 months</time_frame>
    <description>To assess the impact of seric albumin on the response to CRT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>seric gammaglutamyltranferase</measure>
    <time_frame>9 months</time_frame>
    <description>To assess the impact of seric gammaglutamyltranferase on the response to CRT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">150</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>CRT</arm_group_label>
    <description>Patients over 70 years age, selected for CRT according to the ESC 2013 guidelines.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Frailty</intervention_name>
    <description>CRT device is implanted in all patients selected for the study. Frailty is evaluated before implant and defined as &lt;14/17 points using the ONCODAGE score</description>
    <arm_group_label>CRT</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of &gt; 70 years age, selected for CRT according to the ESC 2013 guidelines
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of &gt; 70 years age,

          -  Selected for CRT according to the ESC 2013 guidelines

        Exclusion Criteria:

          -  patients included in other clinical trial which can interfere with the results of this
             one
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maciej KUBALA</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU; Service de Cardiologie, Rythmologie et Stimulation cardiaque</name>
      <address>
        <city>Amiens</city>
        <zip>80000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2015</study_first_submitted>
  <study_first_submitted_qc>February 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2015</study_first_posted>
  <last_update_submitted>November 30, 2016</last_update_submitted>
  <last_update_submitted_qc>November 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>frailty</keyword>
  <keyword>Heart failure</keyword>
  <keyword>cardiac resynchronization therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

